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CASE REPORT
Plexiform neurofibroma in the 
ear canal of a patient with Type I 
Neurofibromatosis
Mauro Geller1, Luiz Guilherme Darrigo Junior2, 
Aguinaldo Bonalumi Filho3, Marcia Goncalves Ribeiro4
INTRODUCTION
Type 1 neurofibromatosis (NF-1) 
is a multisystem genetic disease with sig-
nificant cutaneous manifestations such as 
café-au-lait spots, freckles and neurofibro-
mas.1 The incidence of NF-1 is about 1 : 2 
500 new births; it affects equally all races 
and both sexes.2 Estimates show that there 
are currently in Brazil about 80 000 cases; 
worldwide, there are about 1.5 million 
cases of NF-1.3
A diagnosis of NF-1, according 
to criteria established by the “National 
Institutes of Health” (NIH) in 1987 and 
updated in 1990, depend on a careful cli-
nical examination of the patient, his or her 
parents and siblings, and a detailed family 
medical history; at times, laboratory exams 
are needed.3 The plexiform neurofibroma 
(PN), also named plexiform neuroma, 
pachydermatocele or neurofibromatous 
elephantiasis, has been classified as a 
benign tumor of peripheral nerve sheath 
involving multiple nerve fascicles.3 It is 
a highly vascularized, slow-growing and 
locally invasive non-metastatic tumor.3 PNs 
are one of the important complications of 
NF-1; it may occur in infancy and rarely 
after adolescence. Although frequent in 
patients with NF-1, PNs are not pathogno-
monic of NF-1.4 The most common site is 
the trunk (43%), followed by the head and 
neck (42%) and limbs (15%).5 PNs may give 
rise to malignant peripheral nerve sheath 
tumors (MPNST) that in the past were refer-
red to as neurofibrosarcomas or malignant 
schwannomas; these are the main cause of 
death and the most common malignancies 
in this group of patients.3
NF-2 is characterized by bilateral 
vestibular schwannomas, rarely with cuta-
neous manifestations. Typical lesions are 
schwannomas that may be present in the 
acoustic nerve or in other cranial nerves 
(nerve V, and sometimes nerve X) and 
meningiomas.3
CASE STUDY
KJN, a female Caucasian patient 
aged 8 years and 4 months, from Peru, had 
NF-1 diagnosed at age 7 years; it was the 
first case in her family. Currently she has 
randomly distributed café-au-lait spots, and 
bilateral axillary and inguinal and thoracic 
freckles. The patient has a PN in the left 
auditory canal (Fig. 1), on the face (angle 
of the mandible, submandibular area and 
left temporal area), and on the left portion 
of the tongue (Fig. 1). Other findings inclu-
ded mild diffuse hyperpigmentation on the 
back of both hands, bilateral bone calluses 
on the back of the feet. Lisch nodules (iris 
hamartomas) were absent. Audiometry 
revealed severe conductive hearing loss 
in the left ear. Magnetic resonance ima-
ging revealed anomalous impregnation by 
the paramagnetic contrast agent. Areas of 
signal changes, serpiginous lesions, and 
macroglossia were also found. There was 
a tumor on the left external auditory canal. 
This syndromic clinical picture suggested 
a diagnosis of PN.
DISCUSSION
PNs are an important cause of cli-
nical complications in NF-1; they develop 
mainly in childhood and adolescence. 
The natural history of PNs may vary sig-
nificantly; some lesions may be quiescent 
for long period, while others may grow 
aggressively, especially during childhood 
and adolescence.2 PNs require clinical 
monitoring; tumor growth may cause 
pain, which may also suggest malignant 
transformation, 2 which occurs in 2 to 5% 
of PN patients.2
PNs are relatively common manifes-
tations in NF-1 patients, and may increase 
their morbidity and mortality.2 According 
to Marocchio LS et al., PNs in the mouth of 
NF-1 patients is uncommon; few such cases 
have been described in the literature.6
FINAL COMMENTS
We describe a case of NF-1 with a 
PN in the left auditory canal, resulting in 
severe ipsilateral hearing loss. This is an 
uncommon site in NF-1 patients. In con-
trast, auditory tumors are commonly found 
in NF-2 patients. To our knowledge, this is 
the first description of a case of PN in the 
auditory canal in an NF-1 patient.
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Figure 1. Plexiform neurofibroma in the left auditory canal and the 
tongue.
